D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 89 Citations 35,369 221 World Ranking 6196 National Ranking 3436

Research.com Recognitions

Awards & Achievements

2009 - Member of the National Academy of Medicine (NAM)

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Cancer
  • DNA

Eric C. Holland mainly investigates Cancer research, Glioma, Pathology, Protein kinase B and Signal transduction. His biological study spans a wide range of topics, including Endocrinology, Internal medicine, Stem cell, Nestin and PI3K/AKT/mTOR pathway. Eric C. Holland conducts interdisciplinary study in the fields of Glioma and Context through his research.

The concepts of his Pathology study are interwoven with issues in Oligodendroglial Tumor, Genetically engineered, In vivo and Oligoastrocytoma. His work in Protein kinase B addresses subjects such as Regulation of gene expression, which are connected to disciplines such as microRNA, Tensin, Transcriptome, Transcriptional regulation and Anti-apoptotic Ras signalling cascade. His Signal transduction research includes elements of Cell cycle and PDGFB.

His most cited work include:

  • A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival (2094 citations)
  • CSF-1R inhibition alters macrophage polarization and blocks glioma progression (1073 citations)
  • Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice (765 citations)

What are the main themes of his work throughout his whole career to date?

His primary scientific interests are in Cancer research, Glioma, Pathology, Cell biology and Glioblastoma. Eric C. Holland has researched Cancer research in several fields, including Protein kinase B, Carcinogenesis, Immunology, Platelet-derived growth factor receptor and Stem cell. His PI3K/AKT/mTOR pathway research extends to the thematically linked field of Protein kinase B.

While the research belongs to areas of Glioma, Eric C. Holland spends his time largely on the problem of Internal medicine, intersecting his research to questions surrounding Endocrinology. Eric C. Holland has researched Pathology in several fields, including Magnetic resonance imaging and Oligodendroglioma. His Cell biology study incorporates themes from Cell cycle, Cell culture and Gene expression.

He most often published in these fields:

  • Cancer research (57.77%)
  • Glioma (45.45%)
  • Pathology (18.18%)

What were the highlights of his more recent work (between 2018-2021)?

  • Cancer research (57.77%)
  • Glioma (45.45%)
  • Immune system (5.57%)

In recent papers he was focusing on the following fields of study:

Eric C. Holland spends much of his time researching Cancer research, Glioma, Immune system, Glioblastoma and Carcinogenesis. His Cancer research research incorporates elements of Abscopal effect, Immunotherapy and Immunity. His Glioma research integrates issues from Patterns of failure, Confidence interval, Treatment failure, Radiosurgery and Salvage therapy.

Eric C. Holland interconnects Interferon, Macrophage and Platelet-derived growth factor receptor in the investigation of issues within Immune system. In his research on the topic of Glioblastoma, Internal medicine and Oncology is strongly related with Relevance. His work carried out in the field of Carcinogenesis brings together such families of science as DNA damage, Hippo signaling pathway, Cell growth, Mutant and Cell biology.

Between 2018 and 2021, his most popular works were:

  • Challenges to curing primary brain tumours (159 citations)
  • Genetic programming of macrophages to perform anti-tumor functions using targeted mRNA nanocarriers (84 citations)
  • Genetic programming of macrophages to perform anti-tumor functions using targeted mRNA nanocarriers (84 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Cancer
  • DNA

His primary areas of investigation include Cancer research, Glioma, Immunotherapy, Immune system and Isocitrate dehydrogenase. His Cancer research research includes elements of Cell, Abscopal effect, Transcription factor, Immunity and Mesenchymal stem cell. Brain tumor is closely connected to T cell in his research, which is encompassed under the umbrella topic of Cell.

Eric C. Holland has included themes like Lesion, Platelet-derived growth factor, Platelet-derived growth factor receptor and Epidermal growth factor receptor in his Abscopal effect study. His research integrates issues of Cancer cell, Inflammation, Chemokine, Microglia and Innate immune system in his study of Glioma. His Mutant study also includes fields such as

  • Copy number analysis together with Internal medicine and Oncology,
  • Epigenome, which have a strong connection to Carcinogenesis.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival

Michel Lacroix;Dima Abi-Said;Daryl R. Fourney;Ziya L. Gokaslan.
Journal of Neurosurgery (2001)

2910 Citations

CSF-1R inhibition alters macrophage polarization and blocks glioma progression

Stephanie M Pyonteck;Leila Akkari;Alberto J Schuhmacher;Robert L Bowman.
Nature Medicine (2013)

1327 Citations

Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice

Eric C. Holland;Joseph Celestino;Chengkai Dai;Laura Schaefer.
Nature Genetics (2000)

1053 Citations

A brain tumor molecular imaging strategy using a new triple-modality MRI-photoacoustic-Raman nanoparticle

Moritz F Kircher;Adam de la Zerda;Jesse V Jokerst;Cristina L Zavaleta.
Nature Medicine (2012)

956 Citations

Differential exoprotease activities confer tumor-specific serum peptidome patterns

Josep Villanueva;David R. Shaffer;John Philip;Carlos A. Chaparro.
Journal of Clinical Investigation (2005)

902 Citations

Identification of a multipotent astrocytic stem cell in the immature and adult mouse brain

Eric D. Laywell;Pasko Rakic;Valery G. Kukekov;Eric C. Holland.
Proceedings of the National Academy of Sciences of the United States of America (2000)

885 Citations

PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells.

Anne Marie Bleau;Dolores Hambardzumyan;Tatsuya Ozawa;Elena I. Fomchenko.
Cell Stem Cell (2009)

843 Citations

Glioblastoma multiforme: The terminator

Eric C. Holland.
Proceedings of the National Academy of Sciences of the United States of America (2000)

812 Citations

PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo

Chengkai Dai;Joseph C. Celestino;Yoshifumi Okada;David N. Louis.
Genes & Development (2001)

780 Citations

Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma

Jason T. Huse;Eric C. Holland.
Nature Reviews Cancer (2010)

775 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Eric C. Holland

Stefan M. Pfister

Stefan M. Pfister

German Cancer Research Center

Publications: 107

Kenneth D. Aldape

Kenneth D. Aldape

Princess Margaret Cancer Centre

Publications: 102

Patrick Y. Wen

Patrick Y. Wen

Harvard University

Publications: 93

Andreas von Deimling

Andreas von Deimling

Heidelberg University

Publications: 91

Mitchel S. Berger

Mitchel S. Berger

University of California, San Francisco

Publications: 90

Jeremy N. Rich

Jeremy N. Rich

University of Pittsburgh

Publications: 87

Michael Weller

Michael Weller

University of Zurich

Publications: 85

Wolfgang Wick

Wolfgang Wick

German Cancer Research Center

Publications: 76

Timothy F. Cloughesy

Timothy F. Cloughesy

University of California, Los Angeles

Publications: 69

Justin D. Lathia

Justin D. Lathia

Cleveland Clinic Lerner College of Medicine

Publications: 67

Michael D. Taylor

Michael D. Taylor

University of Toronto

Publications: 65

David H. Gutmann

David H. Gutmann

Washington University in St. Louis

Publications: 62

Felix Sahm

Felix Sahm

University Hospital Heidelberg

Publications: 62

Keith L. Ligon

Keith L. Ligon

Harvard University

Publications: 61

Paul S. Mischel

Paul S. Mischel

Stanford University

Publications: 60

Mark R. Gilbert

Mark R. Gilbert

The University of Texas MD Anderson Cancer Center

Publications: 60

Trending Scientists

Bernd Hamann

Bernd Hamann

University of California, Davis

Yiannis Demiris

Yiannis Demiris

Imperial College London

Pratima Bansal

Pratima Bansal

University of Western Ontario

Jordi Torres

Jordi Torres

Universitat Politècnica de Catalunya

Long Bao Le

Long Bao Le

Institut National de la Recherche Scientifique

Mingwu Shen

Mingwu Shen

Donghua University

Tetsuo Asai

Tetsuo Asai

Gifu University

Koichi Akashi

Koichi Akashi

Kyushu University

Martin Romantschuk

Martin Romantschuk

University of Helsinki

Ming-ko Woo

Ming-ko Woo

McMaster University

Ruoying He

Ruoying He

North Carolina State University

Afaf Girgis

Afaf Girgis

University of New South Wales

Monica Rosselli

Monica Rosselli

Florida Atlantic University

Paul A. Anderson

Paul A. Anderson

University of Wisconsin–Madison

Nanduri R. Prabhakar

Nanduri R. Prabhakar

University of Chicago

Stephen F. King

Stephen F. King

University of Southampton

Something went wrong. Please try again later.